EPO and amyotrophic lateral sclerosis: The observed low EPO expression in ALS brains, compared to ischemic and inflammatory conditions, may reflect a dysregulated cytokine pathway as part of the disease pathomechanism, an adaptation to chronic hypoxia, or an abnormal hypoxia response in general (Sato et al., 2012).